Board of Directors

Mikael Smedeby

Co-Founder, Chairman of the board

  • Master of Law, Uppsala University
  • Partner at Lindahl Law firm
  • Over 20 years of experience in capital markets, mergers & acquisitions
  • Vast experience as a board member in public listed companies and financial institutions.
  • Chairman of the Board of Coeli Holding AB and Sallengruppen AB (including subsidiaries)
  • Board member of Smedeby Förvaltning AB.

Experience and previous assignments
General Counsel, Structures Freemont SA. Active as a lawyer since 1994. Member of the Swedish Bar Association. Executive positions at Advokatfirman Lindahl, including Managing Partner and Chairman of the Board. Member of the Board of Directors of BioArctic, 2014–2017. Special experience in corporate law, mergers and acquisitions, financing and licensing.

Ulf Landegren

Co-Founder & board member

  • Professor of Molecular Medicine, Uppsala University
  • Invented 46 patents/applications
  • Research in his lab has resulted in 10 companies, including ParaAllele, Olink Bioscience (renamed Navinci), Halo Genomics, Q-linea, Olink Proteomics and Rarity Bioscience
  • Member of EMBO and the Royal Swedish Academy of Sciences
  • Former senior visiting scientist at Riken, Yokohama and a Fellow of School of Engineering at Tokyo University

Nils Landegren

Board member

  • MD, PhD, Uppsala University
  • Assistant Professor in Experimental Medical Genomics and group leader at Uppsala University
  • ERC Starting Grant recipient
  • Postdoc at Karolinska Institute, 2016-2020
  • Combined clinical and research internship in Uppsala, 2016-2018

Per Matsson

Co-Founder, Dept Chairman of the board

  • MBA, PhD Biology SLU
  • Served as CSO of ThermoFisher ImmunoDiagnostics division (Phadia AB) for 9 years
  • Founder/co-founder of several early stage life science companies
  • Over 30 years of experience in IVD product development and the international Life Science industry, including R&D, medical and regulatory affairs, IP rights, strategy, mergers & acquisitions, and business development
  • Chairman of Scandinavian CLC board of EIT Health
  • Associate professor at Uppsala University and Swedish Agricultural University

Experience and previous assignments
Head of R&D (immunology) at Sanofi Diagnostics Pasteur Inc. VP of R&D at Pharmacia Diagnostics AB, with development and registration of diagnostic products throughout the world including Europe, US and Japan.

Idar Kreutzer

Board member

  • Master of Finance & Business NHH
  • Prior CEO of Storebrand and board member at several large corporations, including Hydor, Orkla, Norske Skog and more
  • CEO of Finance Norway
  • Member of the board at Aschehoug Forlag, NHH School of economics
  • Member of the Board of the University of Oslo
  • Member of The Minister of Climate and Environment’s Climate Policy Council, since 2014
  • Chairs the Nomination Committee at Orkla AS
  • Deputy Chairman of the Corporate Assembly of Statoil AS. Member of the Corporate Assembly of Norsk Hydro ASA
  • Member of the Strategy Council for the Norwegian Government Pension Fund Global since 2013

Experience and previous assignments
Former member of the World Business Council for Sustainable Development (WBCSD) and has Co-Chaired their Vision 2050. Former member of The Norwegian Commission for Green Competitiveness (2015-2016). Appointed member of the Strategy Council for the Norwegian Government Pension Fund Global in 2013.

Ove Öhman

Advisor

  • Master of Science Linköping University, IMD Business school
  • CEO and co-founder at Astrego Diagnostics
  • Vast experience as a board member in IVD and lifescience startups
  • co-founder from several successful companies like Ginolis and Åmic

Experience and previous assignments
Former senior research fellow at J&J and Pharmacia. Serial Entrepreneur, with several successful ventures.